文献速递产科母胎医学

早产与足月 gestation 严重子痫前期、HELLP 综合征及子痫的发病率与危险因素:基于人群研究

Incidence and risk factors for severe preeclampsia, hemolysis, elevated liver enzymes, and low platelet count syndrome, and eclampsia at preterm and term gestation: a population-based study.
PubMed 文献 · Am J Obstet Gynecol · 2021-05-08

本研究基于加拿大2012-2016年1078323例单胎分娩的回顾性队列,评估严重子痫前期、HELLP综合征和子痫的孕龄别发病率及危险因素。结果显示三者的发生率分别为2.35、2.47和0.43/1000单胎妊娠;足月严重子痫前期风险低于早产,子痫风险足月高于早产,HELLP综合征两者相似。慢性合并症和胎儿先天畸形对早产发病的影响更强,年轻母亲子痫和足月严重子痫前期风险更高,高龄则与严重子痫前期和HELLP综合征风险升高相关。

要点

  • 严重子痫前期、HELLP综合征、子痫发生率分别为2.35、2.47、0.43/1000单胎妊娠。
  • 足月严重子痫前期风险低于早产(0.87 vs 1.54/1000),子痫风险足月高于早产(0.33 vs 0.12/1000)。
  • 慢性合并症和胎儿先天畸形对早产发病的影响更强,初产是全部结局的危险因素。

核心结论

  • 足月时严重子痫前期风险下降,子痫风险上升,HELLP综合征风险在早产与足月间相似。
  • 年轻母亲(<25岁)与子痫及足月严重子痫前期风险升高相关,高龄(≥35岁)与严重子痫前期和HELLP综合征风险升高相关。
  • 孕前合并症和胎儿先天畸形与早产期严重子痫前期、HELLP综合征及子痫的关联更强。

研究设计与样本

  • 回顾性、基于人群的队列研究,纳入加拿大(除魁北克)2012-2016年所有单胎住院分娩(N=1,078,323)。
  • 主要结局数据来自加拿大卫生信息研究所摘录的分娩住院记录,采用Cox回归评估独立危险因素及早产(<37周)与足月(≥37周)效应差异。

主要发现

  • 严重子痫前期(n=2533)、HELLP综合征(n=2663)、子痫(n=465)的发生率分别为2.35、2.47、0.43/1000单胎妊娠。
  • 足月与早产严重子痫前期累积发生率分别为0.87 vs 1.54/1000(率比0.57,95%CI 0.53-0.62)。
  • HELLP综合征足月与早产发生率分别为1.32 vs 1.23/1000(率比0.93,95%CI 0.86-1.00)。
  • 子痫早产与足月发生率分别为0.12 vs 0.33/1000(率比2.64,95%CI 2.16-3.23)。
  • 初产是所有结局的危险因素,社会经济地位与严重子痫前期呈负相关。

临床怎么用

  • 临床需关注足月子痫风险升高,对足月孕妇保持子痫警觉。
  • 对<25岁年轻母亲警惕子痫和足月严重子痫前期,对≥35岁高龄母亲警惕严重子痫前期和HELLP综合征。
  • 合并慢性疾病或胎儿先天畸形者应加强早产期严重子痫前期、HELLP综合征及子痫的监测。

局限性

  • 原文未明确报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: The majority of previous studies on severe preeclampsia, eclampsia, and hemolysis, elevated liver enzymes, and low platelet count syndrome were hospital-based or included a relatively small number of women. Large, population-based studies examining gestational age-specific incidence patterns and risk factors for these severe pregnancy complications are lacking. OBJECTIVE: This study aimed to assess the gestational age-specific incidence rates and risk factors for severe preeclampsia, hemolysis, elevated liver enzymes, and low platelet count syndrome, and eclampsia. STUDY DESIGN: We carried out a retrospective, population-based cohort study that included all women with a singleton hospital birth in Canada (excluding Quebec) from 2012 to 2016 (N=1,078,323). Data on the primary outcomes (ie, severe preeclampsia, hemolysis, elevated liver enzymes, and low platelet count syndrome, and eclampsia) were obtained from delivery hospitalization records abstracted by the Canadian Institute for Health Information. A Cox regression was used to assess independent risk factors (eg, maternal age and chronic comorbidity) for each primary outcome and to assess differences in the effects at preterm vs term gestation (<37 vs ≥37 weeks). RESULTS: The rates of severe preeclampsia (n=2533), hemolysis, elevated liver enzymes, and low platelet count syndrome (n=2663), and eclampsia (n=465) were 2.35, 2.47, and 0.43 per 1000 singleton pregnancies, respectively. The cumulative incidence of term-onset severe preeclampsia was lower than that of preterm-onset severe preeclampsia (0.87 vs 1.54 per 1000; rate ratio, 0.57; 95% confidence intervals, 0.53-0.62), the rates of hemolysis, elevated liver enzymes, and low platelet count syndrome were similar (1.32 vs 1.23 per 1000; rate ratio, 0.93; 95% confidence interval, 0.86-1.00), and the preterm-onset eclampsia rate was lower than the term-onset rate (0.12 vs 0.33 per 1000; rate ratio, 2.64; 95% confidence interval, 2.16-3.23). For each primary outcome, chronic comorbidity and congenital anomalies were stronger risk factors for preterm- vs term-onset disease. Younger mothers (aged <25 years) were at higher risk for severe preeclampsia at term and for eclampsia at all gestational ages, whereas older mothers (aged ≥35 years) had elevated risks for severe preeclampsia and hemolysis, elevated liver enzymes, and low platelet count syndrome. Regardless of gestational age, nulliparity was a risk factor for all outcomes, whereas socioeconomic status was inversely associated with severe preeclampsia. CONCLUSION: The risk for severe preeclampsia declined at term, eclampsia risk increased at term, and hemolysis, elevated liver enzymes, and low platelet count syndrome risk was similar for preterm and term gestation. Young maternal age was associated with an increased risk for eclampsia and term-onset severe preeclampsia. Prepregnancy comorbidity and fetal congenital anomalies were more strongly associated with severe preeclampsia, hemolysis, elevated liver enzymes, and low platelet count syndrome, and eclampsia at preterm gestation.

来源:Am J Obstet Gynecol,查看原文。版权归原作者所有。

引用

  1. Lisonkova S, Bone JN, Muraca GM, et al. Incidence and risk factors for severe preeclampsia, hemolysis, elevated liver enzymes, and low platelet count syndrome, and eclampsia at preterm and term gestation: a population-based study. Am J Obstet Gynecol. 2021. PMID: 33974902. doi:10.1016/j.ajog.2021.04.261

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。